Number 8

Let’s be honest…

Senza categoria 1 September 2005 0

Playwright, dissident, and first President of post-communist Czechoslovakia, Vaclav Havel lost his first wife to cancer in 1996, and was himself diagnosed with lung cancer later that same year. He’d survived years of suppression and [more]

... [ more ]

All in the blood

Senza categoria 1 September 2005 0

Despite being home to three generations of Pavlovskys – Alfredo, the founder, Santiago, now medical director, and Astrid a fellow – Fundaleu is no family firm. On the contrary, it was the Pavlovskys’ commitment to [more]

... [ more ]

ESMO Minimum Clinical Recommendations

Spotlight on 1 September 2005 0

Inadequate diagnostics, inappropriate treatment and poor follow-up deny cancer patients their best chance of survival. Whether you work in a hospital in rural Hungary or at the Jules Bordet in Brussels, ESMO’s updated recommendations spell [more]

... [ more ]

MEPs join forces against cancer

Spotlight on 1 September 2005 0

Europe could do so much more to boost cancer research and ensure all its citizens get good quality treatment. Now a group of politicians has got together to make sure it does. Download full article

... [ more ]

Award for journalist who exposed failings in Hungary’s cancer services

Senza categoria 1 September 2005 0

Viktória Kun, Health Correspondent on the leading Hungarian national daily newspaper Népszabadság, is one of two winners* of this year’s ACE (Awarding Cancer Enlightenment) Reporters’ Award. Here we reprint an article in which she highlights [more]

... [ more ]

Minimising radiotherapy in children with rhabdomyosarcoma

Impact Factor 1 September 2005 0

US and European paediatric oncologists are finally finding common ground over which patients need potentially damaging aggressive local treatment, and which can be spared. Download full article

... [ more ]

Could COX-2s stage a comeback in cancer?

Impact Factor 1 September 2005 0

Hopes for a drug that could inhibit colorectal cancer took a knock last year due to revelations of serious side-effects. But a combination therapy may now offer a way forward. Download full article

... [ more ]

When alternative becomes mainstream

Patient Voice 1 September 2005 0

Evidence base or no evidence base, complementary and alternative medicine use in Europe is edging closer to the rates reported in the US. Can Europe’s doctors learn anything from their American colleagues about how to [more]

... [ more ]

The no-computer virus

Senza categoria 1 September 2005 0

Costs, compatibility and patient privacy have all been cited as reasons why patient records cannot be computerised. But the inability, and reluctance, of doctors and hospitals to use information technology more widely is killing thousands [more]

... [ more ]

The grief that cannot speak its name

Senza categoria 1 September 2005 0

The loss of a sibling can lead to endless suffering when the loss is not given the attention it requires and when grief work is incomplete. A courageous victim of sibling loss tells how she [more]

... [ more ]

A stronger voice within Europe

Editorial 1 September 2005 0

An opportunity is opening up for Europe’s cancer community to increase its influence over health and research policies, by overcoming its fragmentation to speak with a single voice. Download full article

... [ more ]

John Smyth: unity is strength

Cover Story 1 September 2005 0

John Smyth likes to get things done. Head of a major research centre and member of EMEA’s scientific advisory committee, he argues for closer cooperation between academia and industry. He also wants a stronger voice [more]

... [ more ]

On the road to a single European cancer society

Grandround 1 September 2005 0

Members of the Federation of European Cancer Societies are debating how to present a united front to win a better deal for research and treatment. But how can disciplines with different priorities and agendas speak [more]

... [ more ]

Cancer vaccines edge towards success

Drug Watch 1 September 2005 0

A number of cancer vaccines are now entering the final stage of clinical development. Are vaccines finally on their way to enjoying mainstream success in the oncology arena? Download full article

... [ more ]